SAN DIEGO (AP) — SAN DIEGO (AP) — Heron Therapeutics Inc. (HRTX) on Tuesday reported a loss of $3.2 million in its first quarter.
On a per-share basis, the San Diego-based company said it had a loss of 2 cents.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 8 cents per share.
The pharmaceutical company posted revenue of $34.7 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $32.5 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HRTX at https://www.zacks.com/ap/HRTX
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
